AU6802801A - Secreted and transmembrane polypeptides and nucleic acids encoding the same - Google Patents

Secreted and transmembrane polypeptides and nucleic acids encoding the same

Info

Publication number
AU6802801A
AU6802801A AU6802801A AU6802801A AU6802801A AU 6802801 A AU6802801 A AU 6802801A AU 6802801 A AU6802801 A AU 6802801A AU 6802801 A AU6802801 A AU 6802801A AU 6802801 A AU6802801 A AU 6802801A
Authority
AU
Australia
Prior art keywords
secreted
same
nucleic acids
acids encoding
transmembrane polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU6802801A
Inventor
P Baker Kevin
Chen Jian
Desnoyers Luc
Goddard Audrey
J Godowski Paul
L Gurney Austin
Pan James
Smith Victoria
K Watanabe Colin
I Wood William
Zhang Zemin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/005601 external-priority patent/WO2000056889A2/en
Priority claimed from PCT/US2000/005841 external-priority patent/WO2000053758A2/en
Priority claimed from PCT/US2000/006884 external-priority patent/WO2001005972A1/en
Priority claimed from PCT/US2000/008439 external-priority patent/WO2000073454A1/en
Priority claimed from PCT/US2000/013705 external-priority patent/WO2000073445A2/en
Priority claimed from PCT/US2000/014042 external-priority patent/WO2000077037A2/en
Priority claimed from PCT/US2000/014941 external-priority patent/WO2000073348A2/en
Priority claimed from PCT/US2000/015264 external-priority patent/WO2000073452A2/en
Priority claimed from PCT/US2000/020710 external-priority patent/WO2001009327A2/en
Priority claimed from PCT/US2000/023328 external-priority patent/WO2001016318A2/en
Priority claimed from PCT/US2000/030952 external-priority patent/WO2001049715A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US2000/032678 external-priority patent/WO2001040466A2/en
Priority claimed from PCT/US2000/034956 external-priority patent/WO2001046420A2/en
Publication of AU6802801A publication Critical patent/AU6802801A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU6802801A 2000-03-01 2000-11-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same Pending AU6802801A (en)

Applications Claiming Priority (40)

Application Number Priority Date Filing Date Title
PCT/US2000/005601 WO2000056889A2 (en) 1999-03-23 2000-03-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2000/005841 WO2000053758A2 (en) 1999-03-08 2000-03-02 Compositions and methods for the treatment of immune related diseases
US18720200P 2000-03-03 2000-03-03
US18696800P 2000-03-06 2000-03-06
US18932000P 2000-03-14 2000-03-14
US18932800P 2000-03-14 2000-03-14
PCT/US2000/006884 WO2001005972A1 (en) 1999-07-20 2000-03-15 Compositions and methods for the treatment of immune related diseases
US19104800P 2000-03-21 2000-03-21
US19100700P 2000-03-21 2000-03-21
US19082800P 2000-03-21 2000-03-21
US19131400P 2000-03-21 2000-03-21
US19265500P 2000-03-28 2000-03-28
US19303200P 2000-03-29 2000-03-29
US19305300P 2000-03-29 2000-03-29
PCT/US2000/008439 WO2000073454A1 (en) 1999-06-02 2000-03-30 Secreted and transmembrane polypeptides and nucleic acids encoding the same
US19464700P 2000-04-04 2000-04-04
US19444900P 2000-04-04 2000-04-04
US19618700P 2000-04-11 2000-04-11
US19669000P 2000-04-11 2000-04-11
US19597500P 2000-04-11 2000-04-11
US19600000P 2000-04-11 2000-04-11
US19682000P 2000-04-11 2000-04-11
US19812100P 2000-04-18 2000-04-18
US19858500P 2000-04-18 2000-04-18
US19965400P 2000-04-25 2000-04-25
US19939700P 2000-04-25 2000-04-25
US19955000P 2000-04-25 2000-04-25
US20151600P 2000-05-03 2000-05-03
PCT/US2000/013705 WO2000073445A2 (en) 1999-06-02 2000-05-17 Interleukin-1-receptor associated kinase-3 (irak3)
PCT/US2000/014042 WO2000077037A2 (en) 1999-06-15 2000-05-22 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2000/014941 WO2000073348A2 (en) 1999-06-02 2000-05-30 Methods and compositions for inhibiting neoplastic cell growth
PCT/US2000/015264 WO2000073452A2 (en) 1999-06-02 2000-06-02 Compositions and methods for the treatment of immune related diseases
US20983200P 2000-06-05 2000-06-05
PCT/US2000/020710 WO2001009327A2 (en) 1999-07-28 2000-07-28 Method of preventing the injury or death of retinal cells and treating ocular diseases
US64484800A 2000-08-22 2000-08-22
PCT/US2000/023328 WO2001016318A2 (en) 1999-09-01 2000-08-24 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2000/030952 WO2001049715A2 (en) 2000-01-06 2000-11-08 Methods and compositions for inhibiting neoplastic cell growth
PCT/US2000/032678 WO2001040466A2 (en) 1999-12-01 2000-12-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2000/034956 WO2001046420A2 (en) 1999-12-23 2000-12-20 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof
PCT/US2001/006520 WO2001068848A2 (en) 2000-03-01 2001-02-28 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Publications (1)

Publication Number Publication Date
AU6802801A true AU6802801A (en) 2001-09-24

Family

ID=40231083

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6802801A Pending AU6802801A (en) 2000-03-01 2000-11-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001268028A Abandoned AU2001268028A1 (en) 2000-03-01 2001-02-28 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001268028A Abandoned AU2001268028A1 (en) 2000-03-01 2001-02-28 Secreted and transmembrane polypeptides and nucleic acids encoding the same

Country Status (5)

Country Link
EP (1) EP1259614A2 (en)
JP (3) JP2004508805A (en)
AU (2) AU6802801A (en)
CA (10) CA2539214A1 (en)
WO (1) WO2001068848A2 (en)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009155A1 (en) 1997-08-19 1999-02-25 Human Genome Sciences, Inc. 70 human secreted proteins
US7057017B2 (en) 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
ES2286856T3 (en) 1997-09-12 2007-12-01 Biogen Idec Ma Inc. TRAIN RICH RECEIVERS IN CISTEINA.
US6849719B2 (en) 1997-09-17 2005-02-01 Human Genome Sciences, Inc. Antibody to an IL-17 receptor like protein
WO1999014240A1 (en) * 1997-09-17 1999-03-25 Human Genome Sciences, Inc. Interleukin-17 receptor-like protein
US20030039648A1 (en) 1998-09-16 2003-02-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20030130182A1 (en) * 1997-11-05 2003-07-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7446181B2 (en) 1998-01-15 2008-11-04 Millennium Pharmaceuticals, Inc. Antibodies that bind human Dickkopf-1 proteins
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
CA2328496C (en) 1998-05-15 2016-01-05 Genentech, Inc. Il-17 homologous polypeptides and therapeutic uses thereof
US6344541B1 (en) 1998-09-25 2002-02-05 Amgen Inc. DKR polypeptides
US20030187196A1 (en) 1998-12-30 2003-10-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6291663B1 (en) * 1999-03-03 2001-09-18 Board Of Trustees Of The University Of Arkansas TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
US8133734B2 (en) 1999-03-16 2012-03-13 Human Genome Sciences, Inc. Kit comprising an antibody to interleukin 17 receptor-like protein
KR101005124B1 (en) * 1999-05-13 2011-01-04 쉐링 코포레이션 Ox2 receptor homologs
EP1623991A3 (en) * 1999-09-01 2006-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ATE364689T1 (en) 1999-11-18 2007-07-15 Dendreon Corp NUCLEIC ACIDS WHICH CODE FOR ENDOTHELIASES, ENDOTHELIASES, AND THEIR USE
DK1897945T3 (en) * 1999-12-23 2012-05-07 Genentech Inc IL-17 homologous polypeptides and therapeutic uses thereof.
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US20020164745A1 (en) * 2000-06-15 2002-11-07 Meyers Rachel A. 53320, a novel human acyltransferase and uses therefor
US7094566B2 (en) 2000-03-16 2006-08-22 Amgen Inc., IL-17 receptor like molecules and uses thereof
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
WO2001083781A2 (en) * 2000-04-28 2001-11-08 Millennium Pharmaceuticals, Inc. 14094, a novel human trypsin family member and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030031675A1 (en) 2000-06-06 2003-02-13 Mikesell Glen E. B7-related nucleic acids and polypeptides useful for immunomodulation
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
JP2004500872A (en) * 2000-06-22 2004-01-15 バイオジェン　インコーポレイテッド GP354 nucleic acids and polypeptides
EP1294885A2 (en) * 2000-06-30 2003-03-26 Amgen, Inc. B7-like molecules and uses thereof
US7402660B2 (en) 2000-08-02 2008-07-22 The Johns Hopkins University Endothelial cell expression patterns
EP1317472A4 (en) * 2000-08-28 2005-04-27 Human Genome Sciences Inc 17 human secreted proteins
WO2002020800A2 (en) * 2000-09-01 2002-03-14 Millennium Pharmaceuticals, Inc. 16658, 14223, and 16002, NOVEL HUMAN KINASES AND USES THEREFOR
AU2001294703A1 (en) * 2000-09-25 2002-04-08 Millennium Pharmaceuticals, Inc. 32624 a novel human udp-glucuronosyl and glycosyl transferase family member and uses thereof
AU2002217838A1 (en) 2000-11-14 2002-05-27 Bristol-Myers Squibb Company A human serpin secreted from lymphoid cells LSI-01
DE10106835A1 (en) * 2001-02-14 2002-09-05 Basf Lynx Bioscience Ag Signal transduction proteins 15B3, 15B3-1 and 15B3-2 and underlying DNA sequences
JPWO2002064769A1 (en) * 2001-02-15 2004-06-17 塩野義製薬株式会社 New disease markers
EP1873245A1 (en) * 2001-02-28 2008-01-02 Genentech, Inc. Interleukin-8 homologous polypeptides and therapeutic uses thereof
JP2004533222A (en) * 2001-03-12 2004-11-04 インサイト・ゲノミックス・インコーポレイテッド Immunoglobulin superfamily proteins
CA2443123A1 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
AU2002258780A1 (en) 2001-04-11 2002-10-28 Bristol-Myers Squibb Company Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
US7125663B2 (en) 2001-06-13 2006-10-24 Millenium Pharmaceuticals, Inc. Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
AU2002322331B2 (en) * 2001-06-22 2008-01-03 Biogen Idec Ma Inc. Pancam nucleic acids and polypeptides
WO2003004530A1 (en) * 2001-07-06 2003-01-16 Bayer Aktiengesellschaft Regulation of human somatostatin receptor-like protein
AU2002321768B2 (en) * 2001-07-26 2008-03-06 Serono Genetics Institute S.A. GMG-2 polynucleotides and polypeptides and uses thereof
JP4702819B2 (en) 2001-08-01 2011-06-15 生化学工業株式会社 Chondroitin synthase
WO2003018805A1 (en) * 2001-08-23 2003-03-06 Japan Science And Technology Agency Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same
JP2005536439A (en) 2001-09-18 2005-12-02 ジェネンテック・インコーポレーテッド Compositions and methods for tumor diagnosis and treatment
AU2002333862A1 (en) * 2001-09-20 2003-04-01 Bayer Aktiengesellschaft Regulation of human prolyl 4-hydroxylase alpha subunit precursor
EP1469877A4 (en) * 2001-11-02 2008-08-20 Tanox Inc B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
AU2002359815A1 (en) 2001-12-19 2003-07-09 Immunex Corporation C-type lectin polypeptide, polynucleotide and methods of making and use thereof
DE10211088A1 (en) * 2002-03-13 2003-09-25 Ugur Sahin Gene products differentially expressed in tumors and their use
CA2481085A1 (en) * 2002-04-17 2003-10-30 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1507553A2 (en) 2002-05-29 2005-02-23 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Pancreas-specific proteins
JPWO2003102182A1 (en) * 2002-05-31 2005-09-29 猪子　英俊 SLURP-2 gene associated with inflammatory skin disease and use thereof
DE60319529T2 (en) * 2002-05-31 2008-10-23 Seikagaku Corp. CHONDROITINE SYNTHETASE AND ENZYME-CODING NUCLEIC ACID
EP2305710A3 (en) 2002-06-03 2013-05-29 Genentech, Inc. Synthetic antibody phage libraries
WO2004024077A2 (en) * 2002-09-11 2004-03-25 Genentech, Inc. Novel composition and methods for the treatment of psoriasis
DE10242016A1 (en) * 2002-09-11 2004-03-25 Esplora GmbH c/o TU Darmstadt Institut für Biochemie Identifying blood-brain barrier protein, useful e.g. as drug transporter and for treatment or diagnosis, by subtractive hybridization using cDNA from brain capillary cells
DE10254601A1 (en) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
WO2004058817A1 (en) * 2002-12-26 2004-07-15 Takeda Pharmaceutical Company Limited Novel proteins and use thereof
US20060248603A1 (en) * 2002-12-27 2006-11-02 Applied Research Systems Ars Holding N.V. Novel fibrillin-like polypeptides
US20060089297A1 (en) * 2003-01-16 2006-04-27 Herr John C Sperm specific lysozyme-like proteins
US7312197B2 (en) 2003-02-24 2007-12-25 University Of Maryland, Baltimore Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
US20040185559A1 (en) 2003-03-21 2004-09-23 Isis Pharmaceuticals Inc. Modulation of diacylglycerol acyltransferase 1 expression
US20050025763A1 (en) 2003-05-08 2005-02-03 Protein Design Laboratories, Inc. Therapeutic use of anti-CS1 antibodies
US7709610B2 (en) 2003-05-08 2010-05-04 Facet Biotech Corporation Therapeutic use of anti-CS1 antibodies
NZ544317A (en) 2003-07-08 2009-05-31 Genentech Inc IL-17 A/F heterologous polypeptides and therapeutic uses thereof
EP1660537A2 (en) 2003-08-14 2006-05-31 Dyax Corp. Endotheliase-2 ligands
US7825235B2 (en) 2003-08-18 2010-11-02 Isis Pharmaceuticals, Inc. Modulation of diacylglycerol acyltransferase 2 expression
JPWO2005061704A1 (en) * 2003-12-24 2007-07-12 武田薬品工業株式会社 Cancer preventive / therapeutic agent
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
JP2008505182A (en) 2004-07-02 2008-02-21 ジェネンテック・インコーポレーテッド Compositions and methods for the treatment of non-Hodgkin lymphoma
CA2576193A1 (en) 2004-08-03 2006-02-16 Biogen Idec Ma Inc. Taj in neuronal function
EP2336177A1 (en) 2004-08-04 2011-06-22 Amgen, Inc Antibodies to DKK-1
US7544659B2 (en) 2004-08-13 2009-06-09 Genentech, Inc. Promotion of axonal regeneration
EP1863340A2 (en) * 2005-03-11 2007-12-12 Genentech, Inc. Gene disruptions, compositions and methods relating thereto
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
BRPI0620601A2 (en) 2005-12-08 2011-11-16 Medarex Inc isolated human monoclonal antibody or antigen-binding portion thereof, composition, immunoconjugate, isolated nucleic acid molecule, expression vector, host cell, method for preparing an anti-o8e antibody and method for treating or preventing a disease defined by the growth of o8e expressing tumor cells
WO2007107774A2 (en) * 2006-03-22 2007-09-27 Cartela R & D Ab Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
AU2007297565A1 (en) * 2006-04-19 2008-03-27 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto
WO2008019351A2 (en) 2006-08-04 2008-02-14 Isis Pharmaceuticals, Inc. Compositions and their uses directed to diacylglycerol acyltransferase 1
EP2069793B9 (en) 2006-08-29 2017-08-16 Oxford BioTherapeutics Ltd Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer
US8058014B2 (en) 2006-09-29 2011-11-15 University Of Maryland, Baltimore Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2
KR101508086B1 (en) 2008-05-05 2015-04-07 노비뮨 에스 에이 Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
EP2300034B1 (en) 2008-06-02 2018-08-08 Dana-Farber Cancer Institute, Inc. Pharmaceutical composition for use in treating or preventing multiple myeloma or waldenstrom's macroglobulinemia
JP5816558B2 (en) 2009-03-05 2015-11-18 メダレックス・リミテッド・ライアビリティ・カンパニーＭｅｄａｒｅｘ， Ｌ．Ｌ．Ｃ． Fully human antibody specific for CADM1
RU2605318C2 (en) 2009-05-05 2016-12-20 Новиммун С.А. Anti-il-17f antibodies and methods for use thereof
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
WO2013174404A1 (en) 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
AU2013337247B2 (en) 2012-11-05 2018-08-09 Dana-Farber Cancer Institute, Inc. XBP1, CD138, and CS1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions
JP6499079B2 (en) 2012-11-13 2019-04-10 バイオエヌテック アーゲーＢｉｏＮＴｅｃｈ ＡＧ Agents for treating cancer diseases that express claudin
WO2014127785A1 (en) 2013-02-20 2014-08-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2014146672A1 (en) 2013-03-18 2014-09-25 Ganymed Pharmaceuticals Ag Therapy involving antibodies against claudin 18.2 for treatment of cancer
SG10202006563PA (en) 2015-07-10 2020-08-28 Ionis Pharmaceuticals Inc Modulators of diacyglycerol acyltransferase 2 (dgat2)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19817948A1 (en) * 1998-04-17 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh New nucleic acid sequences expressed in uterine cancer tissues, and derived polypeptides, for treatment of uterine and endometrial cancer and identification of therapeutic agents
CA2328895A1 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
CA2383254A1 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU1807401A (en) * 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
AU2001234944A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2420140A1 (en) * 2000-08-24 2002-02-28 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor

Also Published As

Publication number Publication date
JP2006081548A (en) 2006-03-30
JP2004508805A (en) 2004-03-25
CA2534018A1 (en) 2001-09-20
EP1259614A2 (en) 2002-11-27
CA2539214A1 (en) 2001-09-20
CA2533991A1 (en) 2001-09-20
AU2001268028A1 (en) 2001-09-24
CA2533903A1 (en) 2001-09-20
CA2534186A1 (en) 2001-09-20
CA2531917A1 (en) 2001-09-20
JP2008301822A (en) 2008-12-18
WO2001068848A3 (en) 2002-08-29
CA2401448A1 (en) 2001-09-20
CA2534030A1 (en) 2001-09-20
WO2001068848A2 (en) 2001-09-20
CA2533831A1 (en) 2001-09-20
CA2534391A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
AU6802801A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU7315001A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU6531101A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU1661002A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL139686A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL188580A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU7573000A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2055401A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2883700A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2883900A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
IL141535A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1490386A4 (en) Novel polypeptides and nucleic acids encoding the same
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
EP1173456A4 (en) Secreted proteins and nucleic acids encoding them
AU2001249394A1 (en) Secreted proteins and polynucleotides encoding them
AU2002367815A8 (en) Novel nucleic acids and secreted polypeptides
AU2001239889A1 (en) Polypeptides and nucleic acids encoding same
KR100514265B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
KR100473125B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
KR100528420B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
KR100498658B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
AU4587101A (en) Novel human secreted proteins and polynucleotides encoding the same
AU2001234896A1 (en) Novel polypeptides and nucleic acids encoding same
IL142673A0 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU5152700A (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same